Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Cardiology

• Publication date

  2007-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJCARD.2007.03.091PMID 17697836
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of platelet function, a method comparison

  2006cited by this paper
• Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis.

  2006cited by this paper
• Young thrombocytes initiate the formation of arterial thrombi in zebrafish.

  2005cited by this paper
• Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug.

  2005cited by this paper
• Costimulation of the Gi‐coupled ADP receptor and the Gq‐coupled TXA2 receptor is required for ERK2 activation in collagen‐induced platelet aggregation

  2004cited by this paper
• Platelet Activity in Washed Platelet Concentrates

  2004cited by this paper
• Role of Extracellular Ionized Calcium in the In Vitro Assessment of GPIIb/IIIa Receptor Antagonists

  2004cited by this paper
• Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets.

  2003cited by this paper
• Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban.

  2003cited by this paper
• Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E

  2003cited by this paper
• Dynamics of GPIIb/IIIa-mediated platelet-platelet interactions in platelet adhesion/thrombus formation on collagen in vitro as revealed by videomicroscopy.

  2003cited by this paper
• Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.

  2002cited by this paper
• Differential Effects of Citrate Versus PPACK Anticoagulation on Measured Platelet Inhibition by Abciximab, Eptifibatide and Tirofiban

  2001cited by this paper
• Effect of Ca2+ Chelation on the Platelet Inhibitory Ability of the GPIIb/IIIa Antagonists Abciximab, Eptifibatide and Tirofiban

  2001cited by this paper
• Time and Dose Dependent Augmentation of Inhibitory Effects of Abciximab by Aspirin

  2001cited by this paper
• Platelet Reactivity Characterized Prospectively: A Determinant of Outcome 90 Days After Percutaneous Coronary Intervention

  2001cited by this paper
• In vivo biotinylation studies: specificity of labelling of reticulated platelets by thiazole orange and mepacrine

  2000cited by this paper
• Effect of Ca2+ on GP IIb-IIIa interactions with integrilin: enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate.

  1997cited by this paper
• Differential effects of anticoagulants on the activation of platelets ex vivo.

  1997cited by this paper
• Blood Platelet Count and Function Are Related to Total and Cardiovascular Death in Apparently Healthy Men

  1991cited by this paper
• Platelet hyperreactivity and prognosis in survivors of myocardial infarction.

  1990cited by this paper
• Platelet activation in unstable coronary disease.

  1986cited by this paper
• Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.

  1986cited by this paper
• Gly-Pro-Arg-Pro modifies the glutamine residues in the α- and γ-chains of fibrinogen: inhibition of transglutaminase cross-linking

  1986cited by this paper

• Assessing prognosis by quantifying FcγRIIa on fixed platelets

  2024cites this paper
• Platelet FcγRIIA: An emerging regulator and biomarker in cardiovascular disease and cancer.

  2024cites this paper
• Platelet FcγRIIa Expression in Ischemic Stroke: A Marker of Increased Platelet Reactivity

  2022cites this paper
• The Role of Platelet Function Testing in Improving Clinical Outcomes

  2020cites this paper
• Variation in platelet expression of FcγRIIa after myocardial infarction

  2019cites this paper
• Platelet Function Testing and Clinical Outcomes

  2019cites this paper
• Nanomolar concentrations of adrenaline induce platelet adhesion in vitro

  2013cites this paper
• Hydralazine does not Ameliorate Nitric Oxide Resistance in Chronic Heart Failure

  2010cites this paper
• The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets

  2010cites this paper
• Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses.

  2009cites this paper
• Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs—fact or artifact?

  2009cites this paper
• Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects

  2008cites this paper